EMEA (Europe, Middle East and Africa) Cystic Fibrosis Drugs Market Report 2018

March 2018 | 122 pages | ID: E25E388A705EN
QYResearch

Abstracts

In this report, the EMEA Cystic Fibrosis Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Cystic Fibrosis Drugs for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cystic Fibrosis Drugs market competition by top manufacturers/players, with Cystic Fibrosis Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Actavis
• F. Hoffmann-La Roche
• Gilead Sciences
• Novartis
• Vertex Pharmaceuticals
• Abbott
• Anthera Pharmaceuticals
• Arcturus Therapeutics
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Corbus Pharmaceuticals
• Genzyme
• Insmed
• Johnson & Johnson
• Merck Sharp & Dohme
• Neovii Biotech
• Novo Nordisk
• PharmaSwiss
• Pharmaxis
• Proteostasis Therapeutics
• PTC Therapeutics
• United Medical
• Venus Remedies

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Oral
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Cystic Fibrosis Drugs Market Report 2018

1 CYSTIC FIBROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Cystic Fibrosis Drugs
1.2 Classification of Cystic Fibrosis Drugs
  1.2.1 EMEA Cystic Fibrosis Drugs Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Cystic Fibrosis Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Oral
  1.2.4 Injection
1.3 EMEA Cystic Fibrosis Drugs Market by Application/End Users
  1.3.1 EMEA Cystic Fibrosis Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Other
1.4 EMEA Cystic Fibrosis Drugs Market by Region
  1.4.1 EMEA Cystic Fibrosis Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Cystic Fibrosis Drugs (2013-2025)
  1.5.1 EMEA Cystic Fibrosis Drugs Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Cystic Fibrosis Drugs Revenue and Growth Rate (2013-2025)

2 EMEA CYSTIC FIBROSIS DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Cystic Fibrosis Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Cystic Fibrosis Drugs Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Cystic Fibrosis Drugs Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Cystic Fibrosis Drugs Sale Price by Players (2013-2018)
2.2 EMEA Cystic Fibrosis Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Cystic Fibrosis Drugs Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Cystic Fibrosis Drugs Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Cystic Fibrosis Drugs Sale Price by Type (2013-2018)
2.3 EMEA Cystic Fibrosis Drugs (Volume) by Application
2.4 EMEA Cystic Fibrosis Drugs (Volume and Value) by Region
  2.4.1 EMEA Cystic Fibrosis Drugs Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Cystic Fibrosis Drugs Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Cystic Fibrosis Drugs Sales Price by Region (2013-2018)

3 EUROPE CYSTIC FIBROSIS DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Cystic Fibrosis Drugs Sales and Value (2013-2018)
  3.1.1 Europe Cystic Fibrosis Drugs Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Cystic Fibrosis Drugs Revenue and Growth Rate (2013-2018)
3.2 Europe Cystic Fibrosis Drugs Sales and Market Share by Type
3.3 Europe Cystic Fibrosis Drugs Sales and Market Share by Application
3.4 Europe Cystic Fibrosis Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Cystic Fibrosis Drugs Sales Volume by Countries (2013-2018)
  3.4.2 Europe Cystic Fibrosis Drugs Revenue by Countries (2013-2018)
  3.4.3 Germany Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  3.4.4 France Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  3.4.5 UK Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  3.4.6 Russia Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  3.4.7 Italy Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)

4 MIDDLE EAST CYSTIC FIBROSIS DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Cystic Fibrosis Drugs Sales and Value (2013-2018)
  4.1.1 Middle East Cystic Fibrosis Drugs Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Cystic Fibrosis Drugs Revenue and Growth Rate (2013-2018)
4.2 Middle East Cystic Fibrosis Drugs Sales and Market Share by Type
4.3 Middle East Cystic Fibrosis Drugs Sales and Market Share by Application
4.4 Middle East Cystic Fibrosis Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Cystic Fibrosis Drugs Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Cystic Fibrosis Drugs Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  4.4.4 Israel Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  4.4.5 UAE Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  4.4.6 Iran Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)

5 AFRICA CYSTIC FIBROSIS DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Cystic Fibrosis Drugs Sales and Value (2013-2018)
  5.1.1 Africa Cystic Fibrosis Drugs Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Cystic Fibrosis Drugs Revenue and Growth Rate (2013-2018)
5.2 Africa Cystic Fibrosis Drugs Sales and Market Share by Type
5.3 Africa Cystic Fibrosis Drugs Sales and Market Share by Application
5.4 Africa Cystic Fibrosis Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Cystic Fibrosis Drugs Sales Volume by Countries (2013-2018)
  5.4.2 Africa Cystic Fibrosis Drugs Revenue by Countries (2013-2018)
  5.4.3 South Africa Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Cystic Fibrosis Drugs Sales and Growth Rate (2013-2018)

6 EMEA CYSTIC FIBROSIS DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Actavis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Gilead Sciences
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Vertex Pharmaceuticals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Abbott
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Anthera Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Arcturus Therapeutics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Boehringer Ingelheim
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Chiesi Farmaceutici
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Corbus Pharmaceuticals
6.12 Genzyme
6.13 Insmed
6.14 Johnson & Johnson
6.15 Merck Sharp & Dohme
6.16 Neovii Biotech
6.17 Novo Nordisk
6.18 PharmaSwiss
6.19 Pharmaxis
6.20 Proteostasis Therapeutics
6.21 PTC Therapeutics
6.22 United Medical
6.23 Venus Remedies

7 CYSTIC FIBROSIS DRUGS MANUFACTURING COST ANALYSIS

7.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cystic Fibrosis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cystic Fibrosis Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CYSTIC FIBROSIS DRUGS MARKET FORECAST (2018-2025)

11.1 EMEA Cystic Fibrosis Drugs Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Cystic Fibrosis Drugs Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Cystic Fibrosis Drugs Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Cystic Fibrosis Drugs Price and Trend Forecast (2018-2025)
11.2 EMEA Cystic Fibrosis Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Cystic Fibrosis Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Cystic Fibrosis Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Cystic Fibrosis Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Cystic Fibrosis Drugs Sales Forecast by Type (2018-2025)
11.7 EMEA Cystic Fibrosis Drugs Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cystic Fibrosis Drugs
Figure EMEA Cystic Fibrosis Drugs Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Cystic Fibrosis Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Oral Product Picture
Figure Injection Product Picture
Figure EMEA Cystic Fibrosis Drugs Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Cystic Fibrosis Drugs by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Cystic Fibrosis Drugs Market Size (Million USD) by Region (2013-2025)
Figure Europe Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Cystic Fibrosis Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Cystic Fibrosis Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Cystic Fibrosis Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Cystic Fibrosis Drugs Sales Volume and Growth Rate (2013-2025)
Figure EMEA Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Cystic Fibrosis Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Cystic Fibrosis Drugs Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Cystic Fibrosis Drugs Sales Share by Players (2013-2018)
Figure 2017 Cystic Fibrosis Drugs Sales Share by Players
Figure 2017 Cystic Fibrosis Drugs Sales Share by Players
Figure EMEA Cystic Fibrosis Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Cystic Fibrosis Drugs Revenue (Million USD) by Players (2013-2018)
Table EMEA Cystic Fibrosis Drugs Revenue Share by Players (2013-2018)
Table 2017 EMEA Cystic Fibrosis Drugs Revenue Share by Players
Table 2017 EMEA Cystic Fibrosis Drugs Revenue Share by Players
Table EMEA Cystic Fibrosis Drugs Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Cystic Fibrosis Drugs Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Cystic Fibrosis Drugs Sales Share by Type (2013-2018)
Figure Sales Market Share of Cystic Fibrosis Drugs by Type (2013-2018)
Figure EMEA Cystic Fibrosis Drugs Sales Market Share by Type (2013-2018)
Table EMEA Cystic Fibrosis Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Cystic Fibrosis Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Cystic Fibrosis Drugs by Type in 2017
Table EMEA Cystic Fibrosis Drugs Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Cystic Fibrosis Drugs Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Cystic Fibrosis Drugs Sales Share by Application (2013-2018)
Figure Sales Market Share of Cystic Fibrosis Drugs by Application (2013-2018)
Figure EMEA Cystic Fibrosis Drugs Sales Market Share by Application in 2017
Table EMEA Cystic Fibrosis Drugs Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Cystic Fibrosis Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Cystic Fibrosis Drugs by Region (2013-2018)
Figure EMEA Cystic Fibrosis Drugs Sales Market Share in 2017
Table EMEA Cystic Fibrosis Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Cystic Fibrosis Drugs Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Cystic Fibrosis Drugs by Region (2013-2018)
Figure EMEA Cystic Fibrosis Drugs Revenue Market Share Regions in 2017
Table EMEA Cystic Fibrosis Drugs Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Cystic Fibrosis Drugs Revenue and Growth Rate (2013-2018)
Table Europe Cystic Fibrosis Drugs Sales (K Pcs) by Type (2013-2018)
Table Europe Cystic Fibrosis Drugs Market Share by Type (2013-2018)
Figure Europe Cystic Fibrosis Drugs Market Share by Type in 2017
Table Europe Cystic Fibrosis Drugs Sales (K Pcs) by Application (2013-2018)
Table Europe Cystic Fibrosis Drugs Market Share by Application (2013-2018)
Figure Europe Cystic Fibrosis Drugs Market Share by Application in 2017
Table Europe Cystic Fibrosis Drugs Sales (K Pcs) by Countries (2013-2018)
Table Europe Cystic Fibrosis Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Cystic Fibrosis Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Cystic Fibrosis Drugs Sales Market Share by Countries in 2017
Table Europe Cystic Fibrosis Drugs Revenue (Million USD) by Countries (2013-2018)
Table Europe Cystic Fibrosis Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Cystic Fibrosis Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Cystic Fibrosis Drugs Revenue Market Share by Countries in 2017
Figure Germany Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Cystic Fibrosis Drugs Sales (K Pcs) by Type (2013-2018)
Table Middle East Cystic Fibrosis Drugs Market Share by Type (2013-2018)
Figure Middle East Cystic Fibrosis Drugs Market Share by Type (2013-2018)
Table Middle East Cystic Fibrosis Drugs Sales (K Pcs) by Applications (2013-2018)
Table Middle East Cystic Fibrosis Drugs Market Share by Applications (2013-2018)
Figure Middle East Cystic Fibrosis Drugs Sales Market Share by Application in 2017
Table Middle East Cystic Fibrosis Drugs Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Cystic Fibrosis Drugs Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Cystic Fibrosis Drugs Sales Volume Market Share by Countries in 2017
Table Middle East Cystic Fibrosis Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East Cystic Fibrosis Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Cystic Fibrosis Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Cystic Fibrosis Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Cystic Fibrosis Drugs Sales (K Pcs) by Type (2013-2018)
Table Africa Cystic Fibrosis Drugs Sales Market Share by Type (2013-2018)
Figure Africa Cystic Fibrosis Drugs Sales Market Share by Type (2013-2018)
Figure Africa Cystic Fibrosis Drugs Sales Market Share by Type in 2017
Table Africa Cystic Fibrosis Drugs Sales (K Pcs) by Application (2013-2018)
Table Africa Cystic Fibrosis Drugs Sales Market Share by Application (2013-2018)
Figure Africa Cystic Fibrosis Drugs Sales Market Share by Application (2013-2018)
Table Africa Cystic Fibrosis Drugs Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Cystic Fibrosis Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Cystic Fibrosis Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Cystic Fibrosis Drugs Sales Market Share by Countries in 2017
Table Africa Cystic Fibrosis Drugs Revenue (Million USD) by Countries (2013-2018)
Table Africa Cystic Fibrosis Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Cystic Fibrosis Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Cystic Fibrosis Drugs Revenue Market Share by Countries in 2017
Figure South Africa Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Table Actavis Cystic Fibrosis Drugs Basic Information List
Table Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Actavis Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Actavis Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Actavis Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table F. Hoffmann-La Roche Cystic Fibrosis Drugs Basic Information List
Table F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Gilead Sciences Cystic Fibrosis Drugs Basic Information List
Table Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Gilead Sciences Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Gilead Sciences Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Novartis Cystic Fibrosis Drugs Basic Information List
Table Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Novartis Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Novartis Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Basic Information List
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Abbott Cystic Fibrosis Drugs Basic Information List
Table Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Abbott Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Abbott Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Abbott Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Basic Information List
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Anthera Pharmaceuticals Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Arcturus Therapeutics Cystic Fibrosis Drugs Basic Information List
Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Arcturus Therapeutics Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Arcturus Therapeutics Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Boehringer Ingelheim Cystic Fibrosis Drugs Basic Information List
Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Boehringer Ingelheim Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Boehringer Ingelheim Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Basic Information List
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Chiesi Farmaceutici Cystic Fibrosis Drugs Sales Market Share in EMEA (2013-2018)
Figure Chiesi Farmaceutici Cystic Fibrosis Drugs Revenue Market Share in EMEA (2013-2018)
Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Basic Information List
Table Genzyme Cystic Fibrosis Drugs Basic Information List
Table Insmed Cystic Fibrosis Drugs Basic Information List
Table Johnson & Johnson Cystic Fibrosis Drugs Basic Information List
Table Merck Sharp & Dohme Cystic Fibrosis Drugs Basic Information List
Table Neovii Biotech Cystic Fibrosis Drugs Basic Information List
Table Novo Nordisk Cystic Fibrosis Drugs Basic Information List
Table PharmaSwiss Cystic Fibrosis Drugs Basic Information List
Table Pharmaxis Cystic Fibrosis Drugs Basic Information List
Table Proteostasis Therapeutics Cystic Fibrosis Drugs Basic Information List
Table PTC Therapeutics Cystic Fibrosis Drugs Basic Information List
Table United Medical Cystic Fibrosis Drugs Basic Information List
Table Venus Remedies Cystic Fibrosis Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cystic Fibrosis Drugs
Figure Manufacturing Process Analysis of Cystic Fibrosis Drugs
Figure Cystic Fibrosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cystic Fibrosis Drugs Major Manufacturers in 2017
Table Major Buyers of Cystic Fibrosis Drugs
Table Distributors/Traders List
Figure EMEA Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Cystic Fibrosis Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Cystic Fibrosis Drugs Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Cystic Fibrosis Drugs Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Cystic Fibrosis Drugs Sales Market Share Forecast by Region (2018-2025)
Table EMEA Cystic Fibrosis Drugs Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Cystic Fibrosis Drugs Revenue Market Share Forecast by Region (2018-2025)
Table Europe Cystic Fibrosis Drugs Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Cystic Fibrosis Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Europe Cystic Fibrosis Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Cystic Fibrosis Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Cystic Fibrosis Drugs Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Cystic Fibrosis Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Cystic Fibrosis Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Cystic Fibrosis Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Cystic Fibrosis Drugs Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Cystic Fibrosis Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Africa Cystic Fibrosis Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Cystic Fibrosis Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Cystic Fibrosis Drugs Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Cystic Fibrosis Drugs Sales Market Share Forecast by Type (2018-2025)
Table EMEA Cystic Fibrosis Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Cystic Fibrosis Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources